ANTARES PHARMA, INC. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for May 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 30 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.43 | 13,480 | 32,756 | 1,291,439 | 1.3 M to 1.3 M (-1.03 %) |
May 24 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.50 | 100,000 | 250,000 | 10,965,351 | 11.1 M to 11 M (-0.90 %) |
May 24 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.53 | 94,682 | 239,545 | 11,065,351 | 11.2 M to 11.1 M (-0.85 %) |
May 24 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.53 | 5,318 | 13,455 | 11,160,033 | 11.2 M to 11.2 M (-0.05 %) |
May 22 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.60 | 21,062 | 54,761 | 11,165,351 | 11.2 M to 11.2 M (-0.19 %) |
May 18 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.55 | 100,000 | 255,000 | 11,186,413 | 11.3 M to 11.2 M (-0.89 %) |
May 18 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.52 | 100,000 | 252,000 | 11,286,413 | 11.4 M to 11.3 M (-0.88 %) |
May 16 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.50 | 100,000 | 250,000 | 11,386,413 | 11.5 M to 11.4 M (-0.87 %) |
May 16 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.50 | 100,000 | 250,000 | 11,486,413 | 11.6 M to 11.5 M (-0.86 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 0.85 | 82,500 | 70,125 | 0 | |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.52 | 30,052 | 75,731 | 1,304,919 | 1.3 M to 1.3 M (-2.25 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 0.85 | 82,500 | 70,125 | 1,334,971 | 1.3 M to 1.3 M (+6.59 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.47 | 100,000 | 247,000 | 11,586,413 | 11.7 M to 11.6 M (-0.86 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.36 | 100,000 | 236,000 | 11,686,413 | 11.8 M to 11.7 M (-0.85 %) |
May 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.47 | 150,000 | 371,190 | 11,786,413 | 11.9 M to 11.8 M (-1.26 %) |
May 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.46 | 150,000 | 369,210 | 11,936,413 | 12.1 M to 11.9 M (-1.24 %) |
May 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 0.85 | 30,000 | 25,500 | 0 | |
May 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 0.85 | 30,000 | 25,500 | 12,086,413 | 12.1 M to 12.1 M (+0.25 %) |